Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Early History of Chronic Obstructive Pulmonary Disease 1808-1980.

Watson RA, Pride NB.

COPD. 2016;13(2):262-73. doi: 10.3109/15412555.2015.1043521. Epub 2015 Sep 29.

PMID:
26418529
2.

Glottal Aperture and Buccal Airflow Leaks Critically Affect Forced Oscillometry Measurements.

Bikov A, Pride NB, Goldman MD, Hull JH, Horvath I, Barnes PJ, Usmani OS, Paredi P.

Chest. 2015 Sep;148(3):731-738. doi: 10.1378/chest.14-2644.

PMID:
25742459
3.

Reply from the authors.

Hughes JM, Pride NB.

Am J Respir Crit Care Med. 2013 Mar 15;187(6):660-1. No abstract available.

PMID:
23614143
4.

Reply: Hooray for the VA/TLC and DL(CO)/VA.

Hughes JM, Pride NB.

Am J Respir Crit Care Med. 2013 Jan 1;187(1):107. No abstract available.

PMID:
23397612
5.

Examination of the carbon monoxide diffusing capacity (DL(CO)) in relation to its KCO and VA components.

Hughes JM, Pride NB.

Am J Respir Crit Care Med. 2012 Jul 15;186(2):132-9. doi: 10.1164/rccm.201112-2160CI. Epub 2012 Apr 26. Review.

PMID:
22538804
6.

Relation between trunk fat volume and reduction of total lung capacity in obese men.

Watson RA, Pride NB, Thomas EL, Ind PW, Bell JD.

J Appl Physiol (1985). 2012 Jan;112(1):118-26. doi: 10.1152/japplphysiol.00217.2011. Epub 2011 Sep 22.

7.

Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease.

Paredi P, Goldman M, Alamen A, Ausin P, Usmani OS, Pride NB, Barnes PJ.

Thorax. 2010 Mar;65(3):263-7. doi: 10.1136/thx.2009.120790.

PMID:
20335298
8.

Reduction of total lung capacity in obese men: comparison of total intrathoracic and gas volumes.

Watson RA, Pride NB, Thomas EL, Fitzpatrick J, Durighel G, McCarthy J, Morin SX, Ind PW, Bell JD.

J Appl Physiol (1985). 2010 Jun;108(6):1605-12. doi: 10.1152/japplphysiol.01267.2009. Epub 2010 Mar 18.

9.

Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.

Löfdahl CG, Postma DS, Pride NB, Boe J, Thorén A.

Eur Respir J. 2007 Jun;29(6):1115-9. Epub 2007 Mar 1.

10.

Predictors of COPD symptoms: does the sex of the patient matter?

Watson L, Schouten JP, Löfdahl CG, Pride NB, Laitinen LA, Postma DS; European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

Eur Respir J. 2006 Aug;28(2):311-8. Epub 2006 May 17.

11.

Projections of COPD in males in The Netherlands.

Pride NB.

Eur Respir J. 2006 Jan;27(1):240-1; author reply 241-2. No abstract available.

12.

Ageing and changes in lung mechanics.

Pride NB.

Eur Respir J. 2005 Oct;26(4):563-5. No abstract available.

13.

Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.

Watson L, Vonk JM, Löfdahl CG, Pride NB, Pauwels RA, Laitinen LA, Schouten JP, Postma DS; European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

Respir Med. 2006 Apr;100(4):746-53. Epub 2005 Sep 30.

14.

Exhaled nitric oxide from lung periphery is increased in COPD.

Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA.

Eur Respir J. 2005 Jul;26(1):52-9.

15.

Evolution of changes in carbon monoxide transfer factor in men with chronic obstructive pulmonary disease.

Osmanliev DP, Joyce H, Watson RA, Pride NB.

Respir Med. 2005 Aug;99(8):1053-60. Epub 2005 Feb 24.

16.

Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias.

Kiri VA, Pride NB, Soriano JB, Vestbo J.

Am J Respir Crit Care Med. 2005 Aug 15;172(4):460-4. Epub 2005 May 18.

PMID:
15901610
17.

Flow dependence and repeatability of interrupter resistance in lower airways and nose.

Eiser N, Phillips C, Wooler P, Pride NB, Doré CJ.

Physiol Meas. 2005 Jun;26(3):143-56. Epub 2005 Feb 1.

PMID:
15798291
18.

Postural changes in nasal and pulmonary resistance in subjects with asthma.

Duggan CJ, Watson RA, Pride NB.

J Asthma. 2004 Oct;41(7):701-7.

PMID:
15584628
19.

Postural changes in lung volumes and respiratory resistance in subjects with obesity.

Watson RA, Pride NB.

J Appl Physiol (1985). 2005 Feb;98(2):512-7. Epub 2004 Oct 8.

20.

Inhaled steroids and mortality in COPD: bias from unaccounted immortal time.

Kiri VA, Vestbo J, Pride NB, Soriano JB.

Eur Respir J. 2004 Jul;24(1):190-1; author reply 191-2. No abstract available.

21.

Inspiratory muscle load and capacity in chronic heart failure.

Hart N, Kearney MT, Pride NB, Green M, Lofaso F, Shah AM, Moxham J, Polkey MI.

Thorax. 2004 Jun;59(6):477-82.

22.
23.

The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom.

Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB.

Chest. 2003 Aug;124(2):474-81.

PMID:
12907531
24.

Carbon monoxide transfer coefficient (transfer factor/alveolar volume) in females versus males.

Hughes JM, Pride NB.

Eur Respir J. 2003 Jul;22(1):186-7. No abstract available. Erratum in: Eur Respir J. 2003 Sep;22(3):570.

25.

Inhaled glucocorticoids in COPD: immortal time bias.

Pride NB, Vestbo J, Soriano JB, Kiri VA.

Am J Respir Crit Care Med. 2003 Jul 1;168(1):127. No abstract available.

PMID:
12870509
26.

Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database.

Soriano JB, Maier WC, Visick G, Pride NB.

Eur J Epidemiol. 2001;17(12):1075-80.

PMID:
12530765
27.

Effect of pattern and severity of respiratory muscle weakness on carbon monoxide gas transfer and lung volumes.

Hart N, Cramer D, Ward SP, Nickol AH, Moxham J, Polkey MI, Pride NB.

Eur Respir J. 2002 Oct;20(4):996-1002.

28.

Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice.

Soriano JB, Vestbo J, Pride NB, Kiri V, Maden C, Maier WC.

Eur Respir J. 2002 Oct;20(4):819-25.

29.

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey.

Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J.

Eur Respir J. 2002 Oct;20(4):799-805.

30.

Diaphragm length during tidal breathing in patients with chronic obstructive pulmonary disease.

Gorman RB, McKenzie DK, Pride NB, Tolman JF, Gandevia SC.

Am J Respir Crit Care Med. 2002 Dec 1;166(11):1461-9. Epub 2002 Sep 11.

PMID:
12406839
31.

Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler.

Johnell O, Pauwels R, Löfdahl CG, Laitinen LA, Postma DS, Pride NB, Ohlsson SV.

Eur Respir J. 2002 Jun;19(6):1058-63.

32.

Effect of severe isolated unilateral and bilateral diaphragm weakness on exercise performance.

Hart N, Nickol AH, Cramer D, Ward SP, Lofaso F, Pride NB, Moxham J, Polkey MI.

Am J Respir Crit Care Med. 2002 May 1;165(9):1265-70.

PMID:
11991876
33.

Chronic obstructive pulmonary disease in the United Kingdom: trends in mortality, morbidity, and smoking.

Pride NB, Soriano JB.

Curr Opin Pulm Med. 2002 Mar;8(2):95-101. Review.

PMID:
11845003
34.

Tests of forced expiration and inspiration.

Pride NB.

Clin Chest Med. 2001 Dec;22(4):599-622, vii. Review.

PMID:
11787654
35.

Smoking cessation: effects on symptoms, spirometry and future trends in COPD.

Pride NB.

Thorax. 2001 Sep;56 Suppl 2:ii7-10. Review. No abstract available.

36.

Inspiratory flow reserve in boys with Duchenne muscular dystrophy.

De Bruin PF, Ueki J, Bush A, Y Manzur A, Watson A, Pride NB.

Pediatr Pulmonol. 2001 Jun;31(6):451-7.

PMID:
11389578
37.

In defence of the carbon monoxide transfer coefficient Kco (TL/VA).

Hughes JM, Pride NB.

Eur Respir J. 2001 Feb;17(2):168-74.

38.

Changes in carbon monoxide transfer over 22 years in middle-aged men.

Watson A, Joyce H, Pride NB.

Respir Med. 2000 Nov;94(11):1103-8.

39.

Effect of supine posture on respiratory mechanics in chronic left ventricular failure.

Yap JC, Moore DM, Cleland JG, Pride NB.

Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1285-91.

PMID:
11029332
40.

Estimation of diaphragm length in patients with severe chronic obstructive pulmonary disease.

McKenzie DK, Gorman RB, Tolman J, Pride NB, Gandevia SC.

Respir Physiol. 2000 Nov;123(3):225-34.

PMID:
11007989
41.

Recent trends in physician diagnosed COPD in women and men in the UK.

Soriano JB, Maier WC, Egger P, Visick G, Thakrar B, Sykes J, Pride NB.

Thorax. 2000 Sep;55(9):789-94.

42.

Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease.

Higham MA, Pride NB, Alikhan A, Morrell NW.

Eur Respir J. 2000 Feb;15(2):281-4.

43.
44.

Breathing in patients with bullous emphysema: why lung volume reduction may work.

Pride NB.

Monaldi Arch Chest Dis. 1998 Aug;53(4):483-5. Review. No abstract available.

PMID:
9828608
45.
46.

The European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and strategies.

Löfdahl CG, Postma DS, Laitinen LA, Ohlsson SV, Pauwels RA, Pride NB.

Respir Med. 1998 Mar;92(3):467-72.

47.

Use of nasal peak flow to assess nasal patency.

Phagoo SB, Watson RA, Pride NB.

Allergy. 1997 Sep;52(9):901-8.

PMID:
9298174
48.

Diaphragm thickness and inspiratory strength in patients with Duchenne muscular dystrophy.

De Bruin PF, Ueki J, Bush A, Khan Y, Watson A, Pride NB.

Thorax. 1997 May;52(5):472-5.

49.

Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis.

Jones HA, Sriskandan S, Peters AM, Pride NB, Krausz T, Boobis AR, Haslett C.

Eur Respir J. 1997 Apr;10(4):795-803.

50.

Size and strength of the respiratory and quadriceps muscles in patients with chronic asthma.

de Bruin PF, Ueki J, Watson A, Pride NB.

Eur Respir J. 1997 Jan;10(1):59-64.

Supplemental Content

Loading ...
Support Center